Ekso Bionics 

$18.26
57
-$0.89-4.65% Today

Statistics

Day High
19.01
Day Low
17.5
52W High
19.15
52W Low
2.82
Volume
1,620,335
Avg. Volume
-
Mkt Cap
47.9M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-1.8
-1.21
-0.62
-0.03
Expected EPS
-0.0626
Actual EPS
N/A

Financials

-63.21%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
35.85MRevenue
-22.66MNet Income

Analyst Ratings

0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EKSO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Resmed
RMD
Mkt Cap28.25B
ResMed Inc. competes in the development, manufacturing, and marketing of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, including sleep apnea, a field closely related to Ekso Bionics' focus on medical devices for physical assistance.
Community Health Systems
CYH
Mkt Cap432.61M
Community Health Systems, Inc. operates hospitals and healthcare facilities, which could be potential users of Ekso Bionics' medical devices, making them indirect competitors in the healthcare solutions market.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet Holdings, Inc. manufactures and markets orthopedic reconstructive products, competing with Ekso Bionics in the broader market for medical devices that aid mobility.
Smith & Nephew
SNN
Mkt Cap12.95B
Smith & Nephew plc designs, manufactures, and markets medical devices for the orthopedic market, competing with Ekso Bionics in the development of technologies for physical rehabilitation.
Medtronic
MDT
Mkt Cap102.97B
Medtronic plc specializes in medical technologies, services, and solutions, including those for spinal and musculoskeletal conditions, making it a competitor in the medical device market alongside Ekso Bionics.
Stryker
SYK
Mkt Cap119.69B
Stryker Corporation specializes in medical technologies, including orthopedics, making it a competitor in the market for devices that support physical mobility and rehabilitation.
Globus Medical
GMED
Mkt Cap10.91B
Globus Medical, Inc. focuses on musculoskeletal solutions, directly competing with Ekso Bionics in the development and marketing of medical devices aimed at improving physical mobility.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing indirectly with Ekson Bionics by offering alternative solutions for patient care.

About

Ekso Bionics Holdings, Inc. is a global innovator in exoskeleton technology, specializing in the creation, production, sale, and leasing of these advanced devices across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company's operations are divided into two distinct segments: EksoHealth and EksoWorks. The EksoHealth division concentrates on engineering, manufacturing, and marketing exoskeletons designed for medical applications. Conversely, the EksoWorks segment develops and commercializes exoskeleton solutions intended for able-bodied individuals, empowering them to perform demanding, repetitive physical tasks for extended durations. Its product portfolio includes EksoNR, a sophisticated wearable bionic suit and rehabilitation tool. This device supports physical therapists and physicians in treating patients recovering from conditions such as acquired brain injury, stroke, and spinal cord injury. Additionally, the EksoUE is an assistive wearable device for the upper extremities, designed to lessen the gravitational load on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. also maintains a licensing agreement with Lockheed Martin Corporation. Founded in 2005, the company maintains its corporate headquarters in Richmond, California.
Show more...
CEO
Mr. Scott G. Davis
Employees
61
Country
United States
ISIN
US2826444000

Listings

0 Comments

Share your thoughts

FAQ

What is Ekso Bionics stock price today?
The current price of EKSO is $18.26 USD — it has decreased by -4.65% in the past 24 hours. Watch Ekso Bionics stock price performance more closely on the chart.
What is Ekso Bionics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ekso Bionics stocks are traded under the ticker EKSO.
Is Ekso Bionics stock price growing?
EKSO stock has risen by +54.75% compared to the previous week, the month change is a +54.75% rise, over the last year Ekso Bionics has showed a +373.06% increase.
What is Ekso Bionics market cap?
Today Ekso Bionics has the market capitalization of 47.9M
When is the next Ekso Bionics earnings date?
Ekso Bionics is going to release the next earnings report on August 03, 2026.
What is Ekso Bionics revenue for the last year?
Ekso Bionics revenue for the last year amounts to 35.85M USD.
What is Ekso Bionics net income for the last year?
EKSO net income for the last year is -22.66M USD.
How many employees does Ekso Bionics have?
As of June 16, 2026, the company has 61 employees.
In which sector is Ekso Bionics located?
Ekso Bionics operates in the Health & Wellness sector.
When did Ekso Bionics complete a stock split?
The last stock split for Ekso Bionics was on June 02, 2025 with a ratio of 1:15.
Where is Ekso Bionics headquartered?
Ekso Bionics is headquartered in San Rafael, United States.